1. Home
  2. AIHS vs XBIO Comparison

AIHS vs XBIO Comparison

Compare AIHS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.40

Market Cap

5.3M

Sector

Finance

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.20

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIHS
XBIO
Founded
2014
N/A
Country
China
United States
Employees
N/A
2
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AIHS
XBIO
Price
$1.40
$2.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
20.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.63
N/A
EPS
N/A
N/A
Revenue
$3,389,072.00
N/A
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$1.90
52 Week High
$8.26
$13.93

Technical Indicators

Market Signals
Indicator
AIHS
XBIO
Relative Strength Index (RSI) 65.87 54.11
Support Level $1.12 $2.38
Resistance Level $1.42 $2.49
Average True Range (ATR) 0.05 0.18
MACD 0.01 0.02
Stochastic Oscillator 85.74 68.75

Price Performance

Historical Comparison
AIHS
XBIO

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: